Torrent Pharmaceuticals

500420 · BSE · INR

4 716,85 ₹Variation par rapport à la clôture précédente: −0,95 %Variation absolue: −45,10 ₹

Clôture · 5 octobre 2026

Profil de la société

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.

Description disponible en anglais.

Informations sur la société

Secteur
Santé
Industrie
Drug Manufacturers - Specialty & Generic
Pays
Inde
Siège
Torrent House, 380009, Ahmedabad
Salariés
17 059
Cotation
500420 · BSE
Devise
INR